Skip to main content

Table 5 Associations between mammographic density at diagnosis and pathological complete response following neoadjuvant chemotherapy - all patients

From: Mammographic density is a potential predictive marker of pathological response after neoadjuvant chemotherapy in breast cancer

 B-IRADSaNN of casesOR (95% CI)
Model 1a114(ref)
b92220.55 (0.15–2.06)
c108170.33 (0.09–1.24)
d1710.11 (0.01–1.16)
Model 2a114(ref)
b92220.47 (0.12–1.89)
c108170.33 (0.08–1.44)
d1710.10 (0.01–1.13)
Model 3a114(ref)
b92220.32 (0.07–1.50)
c108170.30 (0.06–1.45)
d1710.06 (0.01–0.56)
  1. Odds ratio (OR) for pathological complete response (pCR)
  2. Model 1: crude analysis
  3. Model 2: minimally adjusted (age, BMI, menopause, pregnancies, HRT) analysis
  4. Model 3: fully adjusted (model 2 + ER, PR, Ki67, HER2, and tumor size at diagnosis) analysis
  5. aThroughout the table BI-RADS breast composition is intended